Cite
HARVARD Citation
Simpson, E. et al. (2022). Baricitinib 2 mg for the treatment of atopic dermatitis in North America: Long‐term efficacy and patient‐reported outcomes. Dermatologic therapy. 35 (12), p. n/a. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Simpson, E. et al. (2022). Baricitinib 2 mg for the treatment of atopic dermatitis in North America: Long‐term efficacy and patient‐reported outcomes. Dermatologic therapy. 35 (12), p. n/a. [Online].